The necessary conduct: Exploratory multiregional clinical trials in East Asia-Reference-Cited by-同舟云学术

The necessary conduct: Exploratory multiregional clinical trials in East Asia

Published:2021-08-16 Issue:6 Volume:14 Page:2399-2407
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Jeon Inseung¹^ORCID,Kim Yu Kyong²^ORCID,Song Ildae³⁴^ORCID,Yoon Deok Yong¹^ORCID,Huh Ki Young¹^ORCID,Jin Xuanyou¹^ORCID,Yu Kyung‐Sang¹^ORCID,Lee SeungHwan¹^ORCID,Kumagai Yuji⁴,Jang In‐Jin¹^ORCID

Affiliation:

1. Department of Clinical Pharmacology and Therapeutics Seoul National University College of Medicine and Hospital Seoul Korea

2. Department of Clinical Pharmacology and Therapeutics Chungbuk National University College of Medicine and Hospital Cheongju Korea

3. Department of Pharmaceutical Science and Technology Kyungsung University Busan Korea

4. Kitasato Clinical Research Center Kitasato University School of Medicine Kanagawa Japan

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13106

Reference25 articles.

1. Pharmacotherapeutic disparities: Racial, ethnic, and sex variations in medication treatment

2. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

3. Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States

4. Comparison of the Pharmacokinetics of Subcutaneous Ustekinumab between Chinese and Non-Chinese Healthy Male Subjects across Two Phase 1 Studies

5. Extrinsic Factors Influencing Responses to Psychotherapeutic Drugs

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the Speed of Enrollment for Clinical Trials Conducted by Japanese and Global Pharmaceutical Companies;Biological and Pharmaceutical Bulletin;2023-09-01

2. Characteristics of Asian Participation in Multi-regional Clinical Trials Reviewed for Drug Approval in Japan: Opportunities for Collaboration Between South-East Asia, East Asia, and Japan;Therapeutic Innovation & Regulatory Science;2023-08-16

3. Aligning Environmental, Social, and Governance to Clinical Development: Moving Towards More Sustainable Clinical Trials;2023

4. Asia‐Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo;Clinical Pharmacology & Therapeutics;2022-04-17